<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Sanofi-Aventis Gave Fake Ketek Data To The FDA</title>
	<atom:link href="http://www.pharmalot.com/2008/02/sanofi-aventis-gave-fda-fake-ketek-data/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2008/02/sanofi-aventis-gave-fda-fake-ketek-data/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Fri, 10 Feb 2012 18:13:33 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: Simon Passanante - Investigations into fake Ketek data continue</title>
		<link>http://www.pharmalot.com/2008/02/sanofi-aventis-gave-fda-fake-ketek-data/#comment-159526</link>
		<dc:creator>Simon Passanante - Investigations into fake Ketek data continue</dc:creator>
		<pubDate>Fri, 15 Feb 2008 17:09:54 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/02/sanofi-aventis-gave-fda-fake-ketek-data/#comment-159526</guid>
		<description>[...] Pharmalot notes, the FDA subsequently reviewed the 2002 safety study and discovered that several doctors had [...]</description>
		<content:encoded><![CDATA[<p>[...] Pharmalot notes, the FDA subsequently reviewed the 2002 safety study and discovered that several doctors had [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Donna</title>
		<link>http://www.pharmalot.com/2008/02/sanofi-aventis-gave-fda-fake-ketek-data/#comment-157492</link>
		<dc:creator>Donna</dc:creator>
		<pubDate>Thu, 14 Feb 2008 19:15:50 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/02/sanofi-aventis-gave-fda-fake-ketek-data/#comment-157492</guid>
		<description>Lisa,

    Welcome Back.........:)</description>
		<content:encoded><![CDATA[<p>Lisa,</p>
<p>    Welcome Back&#8230;&#8230;&#8230;:)</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Lisa Van S</title>
		<link>http://www.pharmalot.com/2008/02/sanofi-aventis-gave-fda-fake-ketek-data/#comment-157322</link>
		<dc:creator>Lisa Van S</dc:creator>
		<pubDate>Thu, 14 Feb 2008 16:44:05 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/02/sanofi-aventis-gave-fda-fake-ketek-data/#comment-157322</guid>
		<description>Ol Cranky

A female PPD testified before O and I last year.</description>
		<content:encoded><![CDATA[<p>Ol Cranky</p>
<p>A female PPD testified before O and I last year.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Justice in Michigan</title>
		<link>http://www.pharmalot.com/2008/02/sanofi-aventis-gave-fda-fake-ketek-data/#comment-154792</link>
		<dc:creator>Justice in Michigan</dc:creator>
		<pubDate>Wed, 13 Feb 2008 15:52:44 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/02/sanofi-aventis-gave-fda-fake-ketek-data/#comment-154792</guid>
		<description>As usual, agree with OC.  Just want to highlight the FDA side of the story, which is critical.  It appears at least two officers in FDA's Office of Criminal Investigations - created in '92 exactly for such circustances - were blocked by unnamed "senior FDA officials" from probing what Aventis knew about the marked-up study.  

I very much hope we learn the those names.  Just for their own accountability.  But, yes, they would also make good posterfolk for FDA preemption.</description>
		<content:encoded><![CDATA[<p>As usual, agree with OC.  Just want to highlight the FDA side of the story, which is critical.  It appears at least two officers in FDA&#8217;s Office of Criminal Investigations - created in &#8216;92 exactly for such circustances - were blocked by unnamed &#8220;senior FDA officials&#8221; from probing what Aventis knew about the marked-up study.  </p>
<p>I very much hope we learn the those names.  Just for their own accountability.  But, yes, they would also make good posterfolk for FDA preemption.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: ol cranky</title>
		<link>http://www.pharmalot.com/2008/02/sanofi-aventis-gave-fda-fake-ketek-data/#comment-154713</link>
		<dc:creator>ol cranky</dc:creator>
		<pubDate>Wed, 13 Feb 2008 14:59:37 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/02/sanofi-aventis-gave-fda-fake-ketek-data/#comment-154713</guid>
		<description>Submitted in good faith my arse!  If there's any information in the monitoring reports that something was amiss (my guess there is if they have a former PPD CRA as a key witness) or other reports provided to Aventis by the CRO, there should be documentation of how the sponsor handled the issue.  

I've been underwhelmed by PPDs performance for many years and their study management work has been absolute crap even when a monitor indicated problems on a report but &lt;b&gt;it is the responsibility of the study sponsor to ensure the study is compliant with GCP/CFR/ICH&lt;/b&gt;.  Way too many people on the sponsor side think that the transfer of obligations to a 
CRO is a transfer of responsibility.  If the CRO is preventing critical information from bubbling up to the sponsor (and, sometimes, they do), and the sponsor can prove they showed due diligence in the review of all information relayed by the CRO (including monitoring reports) then the sponsor can claim they made a good faith effort.  Otherwise, people down to the study management level at a sponsor need to step up.

The problem is that too many people in study management at the sponsor either just want to make things nicer, are inexperienced, or are absolutely afraid of the consequences they will face by relaying or acting on concerns they have.  The reason for the latter is they've seen what happens to people who do relay or act those concerns and/or don't drop the issue when it has not been addressed adequately.</description>
		<content:encoded><![CDATA[<p>Submitted in good faith my arse!  If there&#8217;s any information in the monitoring reports that something was amiss (my guess there is if they have a former PPD CRA as a key witness) or other reports provided to Aventis by the CRO, there should be documentation of how the sponsor handled the issue.  </p>
<p>I&#8217;ve been underwhelmed by PPDs performance for many years and their study management work has been absolute crap even when a monitor indicated problems on a report but <b>it is the responsibility of the study sponsor to ensure the study is compliant with GCP/CFR/ICH</b>.  Way too many people on the sponsor side think that the transfer of obligations to a<br />
CRO is a transfer of responsibility.  If the CRO is preventing critical information from bubbling up to the sponsor (and, sometimes, they do), and the sponsor can prove they showed due diligence in the review of all information relayed by the CRO (including monitoring reports) then the sponsor can claim they made a good faith effort.  Otherwise, people down to the study management level at a sponsor need to step up.</p>
<p>The problem is that too many people in study management at the sponsor either just want to make things nicer, are inexperienced, or are absolutely afraid of the consequences they will face by relaying or acting on concerns they have.  The reason for the latter is they&#8217;ve seen what happens to people who do relay or act those concerns and/or don&#8217;t drop the issue when it has not been addressed adequately.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Justice in Michigan</title>
		<link>http://www.pharmalot.com/2008/02/sanofi-aventis-gave-fda-fake-ketek-data/#comment-153806</link>
		<dc:creator>Justice in Michigan</dc:creator>
		<pubDate>Wed, 13 Feb 2008 05:45:40 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/02/sanofi-aventis-gave-fda-fake-ketek-data/#comment-153806</guid>
		<description>Every time you think it can't get scuzzier, it gets scuzzier.</description>
		<content:encoded><![CDATA[<p>Every time you think it can&#8217;t get scuzzier, it gets scuzzier.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Dynamic Page Served (once) in 0.201 seconds -->

